Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers

Thomas Efferth1, Manfred Volm2

  • 1Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany. efferth@uni-mainz.de.

Archives of Toxicology
|February 9, 2017
PubMed

Insights

ATP-binding cassette (ABC) transporters detoxify harmful substances, but their roles vary. While crucial for health, they can cause multidrug resistance in cancer and environmental toxicity.

Area of Science:

  • Biochemistry
  • Environmental Science
  • Pharmacology

Background:

  • Organisms possess molecular mechanisms to detoxify and excrete harmful xenobiotics and endogenous toxins.
  • ATP-binding cassette (ABC) transporters are key players in extruding diverse chemical compounds from cells.
  • These transporters are vital for cellular defense and maintaining health across species.

Purpose of the Study:

  • To explore the dual role of ABC transporters in biological systems.
  • To highlight their impact on human health, cancer therapy, and environmental toxicology.
  • To emphasize the need for interdisciplinary research in medicine and environmental science.

Main Methods:

  • Review of existing literature on ABC transporter functions.
  • Analysis of phenotypes associated with ABC transporter expression, including multidrug resistance (MDR) and multi-xenobiotic resistance (MXR).
  • Examination of the implications of ABC transporter activity in cancer chemotherapy and ecotoxicology.

Main Results:

  • ABC transporters exhibit context-dependent effects, leading to beneficial outcomes like carcinogenesis prevention and harmful effects like MDR in tumors.
  • Their activity influences drug absorption, distribution, metabolism, and excretion (ADME) in humans.
  • Inhibition of ABC transporters can aid cancer treatment but blocking their efflux function by pollutants causes ecotoxicity and potential food chain contamination.

Conclusions:

  • ABC transporters play a critical, albeit complex, role in detoxification and cellular protection.
  • Understanding their multifaceted functions is essential for both human medicine and environmental protection.
  • Interdisciplinary collaboration is crucial to address challenges related to ABC transporters in health and the environment.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
85
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
51
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.1K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.4K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.4K
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.9K